| Patent application number | Description | Published |
|---|
| 20090062274 | Pyridopyrimidinone inhibitors of pi3kalpha - The invention is directed to Compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds. | 03-05-2009 |
| 20090163471 | Tropane compounds - A compound according to Formula I or II: | 06-25-2009 |
| 20090203577 | Azepinoindole Derivatives As Pharmaceutical Agents - The present invention relates to compounds of formula I, which exhibit affinity for the farnesoid X receptor. | 08-13-2009 |
| 20090270430 | Pyridopyrimidinone Inhibitors of Pl3Kalpha - The invention is directed to Compounds of Formula I: | 10-29-2009 |
| 20100150827 | PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER - The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer. | 06-17-2010 |
| 20100209340 | PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER - The invention is directed to Compounds of Formula (I). The invention provides compounds that inhibit, regulate, and/or modulate P13K that are useful in the treatment of hyperproliferative diseases, such as cancer. | 08-19-2010 |
| 20100305093 | Inhibitors of mTOR and Methods of Making and Using - The invention is directed to Compounds of Formula I: | 12-02-2010 |
| 20110237608 | Pyridopyrimidinone Inhibitors of PI3Kalpha - The invention is directed to Compounds of Formula I: | 09-29-2011 |
